NSTEMI patients. Complete CRUSADE details have previously been published. 5, 6 Briefly, CRUSADE enrolled patients from 2001 to 2006 with high-risk acute coronary syndrome features and ischemic rest symptoms within 24 hours before presentation. Patient characteristics, in-hospital treatments and outcomes, and discharge therapies were collected in a deidentified fashion. Longitudinal readmission and mortality outcomes were identified from administrative CMS data using inpatient and denominator files, respectively. Outpatient provider claims for services covered under Medicare Part B were examined through the use of carrier files and Healthcare Common Procedure Coding System codes. This study was approved by the Duke University Health System Institutional Review Board.
Patients
We included CRUSADE patients ≥65 years of age with linked and matching CMS data from 2003 to 2006; this time frame was chosen because of the use of a revised case report form that collected more clinical variables. The process for linking patient data using probabilistic matching based on indirect identifiers (eg, age, date of service, and sex) has been previously described. 7 Through this methodology, 72.5% of CRUSADE patients ≥65 years of age were successfully linked with CMS records. We excluded patients presenting with ST-segment-elevation myocardial infarction (STEMI), a population that was not enrolled consistently throughout CRUSADE and that makes up a small minority of the patient population; patients for whom data were collected using the less comprehensive first version of the case report form; patients who died in hospital; and patients with nonmatching CRUSADE and CMS records. Patients transferred to acute care facilities or discharged to a skilled nursing facility or hospice were also excluded, as were patients with first physician follow-up on the same day as discharge. We included only the first admission for patients with multiple hospitalizations captured in CRUSADE, and we excluded hospitals without full revascularization capabilities and low-volume centers (<25 patients).
Definitions and Outcomes
Early follow-up was defined as any physician outpatient evaluation and management visit (Healthcare Common Procedure Coding System codes 992.xx-994.xx) within 7 days after discharge from the index hospitalization. Emergency department visits were not considered early follow-up. Patients who died or were readmitted before receiving physician follow-up within 7 days after discharge were classified as having missing early follow-up status and were excluded from the determination of hospital-level early physician follow-up. Transfers to or from another hospital and rehabilitation admissions were not counted as readmissions. Our primary outcome was allcause readmission within 30 days after discharge from index hospitalization. Secondary outcomes included 30-day all-cause mortality and the composite end point of readmission and mortality.
Statistical Analysis
Rates of early follow-up were calculated for patients without missing follow-up status and reported at the hospital level for the overall study population, as well as by quartiles of hospital early follow-up. We examined baseline patient and in-hospital variables according to quartile of hospital-level early follow-up. Comparisons across quartiles were made for nonmissing values (≈1% missing). Categorical variables were summarized as frequencies and percentages, and continuous variables were presented as medians with interquartile ranges. Pearson χ 2 and Kruskal-Wallis tests were used for comparisons among categorical and continuous variables, respectively. A significance level of 0.05 and 2-sided tests were used for all analyses. Analyses were performed with SAS version 9.2 (SAS Institute, Cary, NC).
We reported the unadjusted cumulative incidence for 30-day readmission, mortality, and composite readmission/mortality. Evaluations of readmission outcomes excluded patients ineligible for Medicare feefor-service insurance within 30 days after discharge from index hospitalization (n=1707), because readmissions for these patients could not be identified. In general, sicker patients with greater comorbidities are seen in follow-up sooner after discharge than less sick patients, but they are also at higher risk of readmission. Consequently, severity of illness may confound evaluations of physician follow-up and outcomes. This may be especially relevant for analyses conducted at the patient level, because there may be dramatic differences in illness severity when individual patients are compared with one another. However, these differences may be reduced when making aggregate comparisons at the hospital level and across multiple sites, because each hospital has a distribution of disease severity. Therefore, to reduce confounding, we chose to perform our analyses at the hospital level and adjusted for patient-level characteristics. We used logistic generalized estimating equations with an exchangeable working correlation matrix to examine relationships between hospital-level rates of early physician follow-up and outcomes. This strategy has been used before to demonstrate the association of early physician followup and risk for readmission after hospitalization for heart failure. 4 When readmission outcomes were modeled, missing continuous covariates were imputed to the median nonmissing value, and missing categorical covariates were imputed to the value of the most frequent group. Rates of missingness were ≤2.2% for all variables, with the exception of hematocrit, creatinine, and troponin, which ranged from 2.4% to 4.1%. Nonlinear continuous covariates were fitted with splines. Hospital early follow-up was examined as a categorical variable for pairwise comparisons between the second through fourth quartiles and the first quartile of hospital follow-up. Hospitallevel early follow-up was also considered a continuous variable. Odds ratios (ORs) for hospital early follow-up were reported per 5% increase in physician follow-up. Three adjustment models were constructed based on patient characteristics, the addition of hospital features to the first model, and the addition of treatment features to the second model. Covariates for adjustment in model 1 included demographic variables (age, sex, race, weight), medical history (current/ recent smoker, hypertension, diabetes mellitus, dyslipidemia, peripheral artery disease, previous percutaneous coronary intervention, previous coronary artery bypass graft surgery, family history of coronary artery disease; previous myocardial infarction [MI], congestive heart failure, and stroke), and in-hospital characteristics (transfer-in status; presentation heart rate; systolic blood pressure; ECG findings; signs of congestive heart failure; baseline hematocrit, troponin, and creatinine; and length of stay). Additional adjustment covariates for model 2 included hospital region, teaching status, bed size, and percentage of black patients treated. Variables added into model 3 included cardiac catheterization, percutaneous coronary intervention, coronary artery bypass graft surgery, discharge medications (aspirin, β-blocker, statin, angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and clopidogrel), smoking cessation counseling, cardiac rehabilitation referral, and diet modification counseling.
We performed sensitivity analyses examining 30-day cardiovascular readmissions, defined by diagnosis-related group codes (see Table  I in the online-only Data Supplement). Additionally, we examined all-cause and cardiovascular 30-day readmissions among high-risk AMI patients, defined as patients with ≥10% predicted mortality calculated with the Global Registry of Acute Coronary Events (GRACE) 6-month postdischarge risk score. 8 Predicted 6-month mortality was calculated using age, history of MI, history of congestive heart failure, pulse, systolic blood pressure, creatinine, cardiac enzymes, ST-segment depression, and in-hospital percutaneous coronary intervention. Patients missing any of these variables were excluded from these analyses (n=1256). Evaluations of early cardiology follow-up used physician specialty codes from outpatient Medicare Part B provider claims to classify cardiologists. Unplanned all-cause readmissions were identified by excluding probable staged revascularization procedures using previously described methodology whereby percutaneous coronary intervention or coronary artery bypass graft surgery procedures associated with primary diagnosis codes unlikely to represent elective admissions were considered unplanned readmissions. 9
Results
Overall, a total of 48 370 CRUSADE patients ≥65 years of age from 448 hospitals had linked longitudinal CMS data September 10, 2013 from 2003 to 2006. We excluded STEMI patients (n=2614) and patients who died in hospital (n=2623), were transferred to acute care facilities (n=4474), or were discharged to a skilled nursing facility or hospice (n=6305). After exclusions ( Figure 1 ), the final analysis population included 25 872 patients from 228 sites.
Among the 228 centers, the median hospital-level percentage of patients receiving early physician follow-up was 23.3%; however, there was wide hospital variation in early follow-up, ranging from 2.6% to 51.6% (interquartile range, 17.7%-29.1%; Figure 2 ). In the overall study population, the median age was 76 years, 44.2% (n=11 438) were female, and 7.6% (n=1953) were black. We examined patient and hospital characteristics according to quartile of hospital-level early follow-up (Table 1) . Compared with hospitals in the lowest 2 quartiles of early follow-up (<17.8% and 17.8%-23.2%), those with most frequent follow-up (23.3%-28.9% and >28.9%) treated a higher proportion of black patients and patients with more comorbidities. Hospitals with higher follow-up rates were also less likely to use percutaneous coronary intervention and coronary artery bypass graft surgery than sites in the lower 3 quartiles and had a slightly longer median length of stay ( Table 2) .
Early Physician Follow-Up and 30-Day Outcomes
Overall, 18.51% of 24 165 patients (n=4474) with Medicare fee-for-service insurance for 30 days after discharge were readmitted. Table 3 shows unadjusted rates of 30-day outcomes according to quartiles of hospital-level early follow-up. There was no significant difference in the unadjusted rates of readmission, mortality, or the composite end point of mortality or readmission across quartiles.
After adjustment for patient demographic and clinical characteristics, no association between hospital-level early follow-up and 30-day readmission was found among pairwise comparisons of quartiles 2 through 4 with quartile 1 of hospital-level early follow-up ( Figure 3 ) or through continuous measurement (adjusted OR per 5% increase in followup, 0.99; 95% confidence interval [CI], 0.97-1.02; P=0.60).
Neither the addition of hospital features (adjusted OR per 5% increase in early follow-up, 0.99; 95% CI, 0.97-1.02; P=0.63) nor further adjustment for treatment features (adjusted OR per 5% increase in early follow-up, 0.99; 95% CI, 0.97-1.02; P=0.57) affected these results.
Sensitivity Analyses
We performed several sensitivity analyses to evaluate the robustness of our primary results ( Figure I in the online-only Data Supplement). First, we assessed whether early physician follow-up may have affected the composite end point of 30-day all-cause readmission or mortality but found, similar to our overall results, no association between the two (OR per 5% increase in early follow-up, 0.99; 95% CI, 0.97-1.02; P=0.51 using the third adjustment model). Second, we examined whether early follow-up was associated with cardiovascular-specific causes of readmission. Overall, 13.2% of patients (n=3024) were readmitted for a cardiovascular cause within 30 days of discharge. Again, there was no association between hospital rates of early physician follow-up and 30-day cardiovascular readmissions (OR per 5% increase, 0.99; 95% CI, 0.96-1.02; P=0.48 using the third adjustment model).
Third, we assessed whether early follow-up was more impactful among higher-risk patients. High-risk was defined as a GRACE 6-month postdischarge mortality of ≥10% ( present in 33.5% of eligible patients [n=7679]). Among highrisk patients, 26.0% were seen by a physician within 7 days of discharge. Although those with high-risk features were more likely to be readmitted within 30 days than low-risk patients (23.4% versus 16.0%; P<0.0001), adjusted analyses showed no association between early physician follow-up and 30-day all-cause readmission in the high-risk patient subgroup (OR per 5% increase in early follow-up, 0.99; 95% CI, 0.96-1.03; P=0.60 using the third model) or 30-day cardiovascular readmission (OR per 5% increase in early follow-up, 0.99; 95% CI, 0.95-1.03; P=0.58 using the third model).
Fourth, we evaluated whether physician specialty might influence the association between cardiology specialty follow-up and readmission. Overall, the median hospital-level early cardiology follow-up rate was low at 5.6% (interquartile range, 2.7%-9.2%). We demonstrated no association between hospital-level early cardiology follow-up and 30-day all-cause readmission (OR per 5% increase in early follow-up, 0.99; 95% CI, 0.95-1.03; P=0.68 using the third adjustment model) or 30-day cardiovascular readmission (OR per 5% increase in early follow-up, 0.98; 95% CI, 0.94-1.03; P=0.43 using the third adjustment model).
We also performed additional analyses to assess for potential relationships between early follow-up and readmission in our cohort ( Figure II in the online-only Data Supplement). To ensure stable estimates of hospital-level early follow-up used in our analyses, we increased the threshold for excluding lowvolume hospitals from ≥25 to ≥50 cases. Among the 22 314 patients treated at 175 sites in this analysis, there was no association of early follow-up with readmission (OR per 5% increase in early follow-up, 1.01; 95% CI, 0.98-1.03; P=0.67 using the third adjustment model).
Next, we included patients discharged to skilled nursing facilities (n=3931) in our analysis, because this population is generally at higher readmission risk owing to disease severity and comorbid conditions, but we failed to demonstrate any relationship between early follow-up and readmission (OR per 5% increase in early follow-up, 0.99; 95% CI, 0.96-1.02; P=0.49 using the third adjustment model). Although CMS policies currently target all-cause readmission, we were interested to see whether there was any potential impact of early followup on unplanned readmissions. Among the 24 165 patients included in our main study population, 15.7% (n=3800) had unplanned 30-day readmissions, yet no relationship between early follow-up and unplanned readmissions was found (OR per 5% increase in early follow-up, 1.00; 95% CI, 0.97-1.02; P=0.84 using the third adjustment model). Our data also do not support an association between early follow-up and readmission among nonrevascularized patients (n=10 061; OR per 5% increase in early follow-up, 0.99; 95% CI, 0.96-1.02; P=0.71 using the third adjustment model). This hypothesis was tested, because this group may be more reliant on antianginal medications for symptom relief and might benefit from earlier physician evaluation of the adequacy of their medication regimens.
We then included an additional measure of socioeconomic status, median household income, in our adjustment model, because patients with lower socioeconomic status may be at higher risk of readmission. Despite this addition, we saw no change in our primary results (OR per 5% increase in early follow-up, 0.99; 95% CI, 0.97-1.02; P=0.59 using the third adjustment model).
Finally, recognizing that both NSTEMI and STEMI patients are included in CMS readmission payment policies, we included an additional 1512 STEMI patients meeting other inclusion and exclusion criteria in our analysis. In this expanded population, we did not find any relationship between early follow-up and readmission (OR per 5% increase in early follow-up, 1.00; 95% CI, 0.97-1.02; P=0.85 using the third adjustment model).
Discussion
In the United States, 30-day readmissions after AMI are common and increase resource use. Among >25 000 older NSTEMI patients in the CRUSADE Registry, we found wide variation among hospitals in early physician follow-up use after discharge. However, we did not find that those hospitals more commonly using early physician follow-up had lower rates of 30-day all-cause readmission. In addition, sensitivity analyses extended these null findings to 30-day cardiovascular readmissions, high-risk subgroups, and early cardiology follow-up. Therefore, these data do not support the hypothesis that more frequent early physician follow-up within a week of discharge can reduce 30-day readmissions in the AMI population. Early follow-up may still be important in managing the transition from hospital to outpatient care after an acute event.
Although it seems intuitive that strategies focusing on the transitional period after hospitalization would be effective in reducing 30-day readmissions, data on these interventions are inconsistent. Randomized trials have shown that comprehensive discharge planning and implementation of care transition teams can reduce readmissions in older and heart failure populations. [10] [11] [12] Observational data also suggest an association between physician follow-up and reduced readmission for Medicare beneficiaries and for patients hospitalized with chronic obstructive pulmonary disease. 13, 14 However, physician follow-up has not been found to reduce readmissions for general medicine patients, 15 and a systematic review of interventions to reduce 30-day readmission found no consistent association of any single intervention or group of interventions with reduced readmission. 16 Although a study found an association between physician follow-up within 7 days of discharge and reduced 30-day readmission in the heart failure population, 4 we failed to demonstrate a similar relationship among patients hospitalized for NSTEMI. Heart failure and chronic obstructive pulmonary disease-2 diseases for which physician follow-up has been linked to reduced readmissions-are more chronic conditions in which careful titration of medications and short-term physiology for recurrence may affect patient symptoms and disease exacerbations. The need for active patient education in heart failure and chronic obstructive pulmonary disease may also make it more plausible that early contact after discharge can reinforce behavioral and medication instructions and subsequently reduce readmission risk. In contrast, postdischarge readmission rates are lower in the AMI population, and these patients may be less likely to have disease-specific decompensation early after the index event, particularly after coronary revascularization and with active secondary prevention medications prescribed at discharge. As a result, the putative benefits of early physician follow-up may be diminished for AMI patients relative to these other conditions.
Other factors specific to AMI may also affect readmission risk. Patients presenting with AMI who experience complications after angiography or revascularization such as contrastinduced nephropathy are at higher risk for 30-day readmission and may require inpatient management for these complications. 17 Furthermore, data suggest that approximately one third to one half of readmissions after incident MI are for unrelated reasons. 17, 18 Likewise, we found that 28.56% of 30-day readmissions after AMI (n=3024) in our study were noncardiovascular. Thus, the unavoidable nature of procedural complications requiring inpatient treatment and the frequency of readmissions unrelated to index admission among AMI patients may partly explain our findings. Although early physician follow-up may play an important role in limiting preventable readmissions in this population, deciphering these events post hoc may be confounded.
Another important outcome we examined was mortality after admission for AMI. In our study, the 30-day mortality rate was only 2.5%. Previous data indicate that interventions focused on transitions of care may improve 1-year and even longer-term survival, 19 ,20 yet when we assessed this, we did not find an association between early physician follow-up and 30-day readmission or mortality. Our findings may be attributable to the low rate of short-term mortality after hospital discharge in our population. Further exploration of the effect of early physician follow-up on longer-term outcomes is warranted.
Although our analysis did not demonstrate an impact of physician follow-up within 7 days of discharge on readmissions, physician visits remain an important component of post-hospitalization transitional care. These visits provide the opportunity to ensure patient understanding of changes to medication regimens and activity limitations, to confirm patient compliance with and tolerance of medications, and to follow up on any outstanding test results. However, there is little current evidence to support scheduling follow-up specifically within the first week after discharge to improve patient outcomes. 4 Indiscriminate application of such a policy could have significant financial implications, and our data do not suggest that this strategy will be effective in the general population to reduce readmissions after AMI. Taken together, our findings that 30-day readmissions are common and are not associated with early follow-up highlight the need both to improve risk stratification to accurately identify AMI patients at highest risk for readmission and to investigate other potential strategies to reduce 30-day readmission after AMI hospitalizations.
Limitations
Our study had several limitations. First, our analysis was observational. Patients treated at hospitals with greater early follow-up were sicker, and the use of statistical adjustment and hospital-level analyses may not have fully accounted for confounding by severity of illness. Second, our study was restricted to Medicare beneficiaries, potentially limiting generalizability to younger patients. Nevertheless, Medicare patients make up a large proportion of MI admissions and are at higher risk of readmission. Third, we defined early followup as a physician visit within 7 days after discharge and examined 30-day outcomes. The 7-day window has previously been studied and was chosen for historical precedent and for clinical plausibility: A large proportion of post-AMI readmissions occur within 15 days of hospitalization and could potentially be prevented by an early physician visit. 18 However, previous studies showing the benefit of physician follow-up on readmission have examined a larger range of time frames for both variables and could be explored in AMI patients. 13, 14 We also chose to evaluate follow-up with any physician because of expected greater primary care physician availability for early follow-up, as well as the important role that primary care physicians play in patient care. A sensitivity analysis examining early cardiology follow-up did not significantly change our primary results.
Fourth, previous analyses have demonstrated improved outcomes with better integration of care from the hospital to outpatient setting, 21 yet we lacked data on other factors that may affect readmission risk, including home health visits, nonphysician medical contacts, degree of coordination of handoffs from inpatient to outpatient providers, and patient education. In our study, early follow-up did not appear to be associated with reduced readmissions in patients at highest risk for mortality; whether these patients also represent the highestrisk group for readmission is unclear, because prediction models for readmission after AMI have generally not performed well. 22 Fifth, we examined the impact of early physician follow-up as an isolated intervention, whereas early followup might prove more effective as part of a bundled strategy. 21 Finally, the hospital-level variable may be too insensitive to detect a relationship between follow-up and readmission using our statistical methodology and among our study population. CRUSADE was a voluntary initiative; hence, participating hospitals were likely more interested in acute coronary syndrome quality improvement. The lack of benefit seen with early follow-up in this hospital-level analysis might be related to high levels of discharge processes and standards for acute coronary syndrome care already in place at sites.
Conclusions
Readmissions after AMI are common, and ≈1 in 5 older NSTEMI patients in our study was readmitted within 30 days after discharge. Most NSTEMI patients were not seen in follow-up by a physician within a week of discharge, although rates of early follow-up varied across sites. Despite this variation, we did not find an association between early physician follow-up and lower rates of 30-day readmission. Therefore, our data suggest that indiscriminate application of an early follow-up policy may not reduce 30-day readmission after AMI. Other approaches to improve readmission rates in this population should be investigated. 
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CLINICAL PERSPECTIvE
In the United States, 30-day readmission rates after acute myocardial infarction are common and are now used as a national hospital performance measure. To date, there are limited proven means of reducing readmissions after acute myocardial infarction, although early outpatient physician follow-up after hospitalization for heart failure has been associated with reduced 30-day readmissions. We studied >25 000 older non-ST-segment myocardial infarction patients in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) Registry. We found that only a minority (23.3%) of acute myocardial infarction patients received early follow-up within 7 days of discharge and that this rate varied widely among hospitals. However, we found no evidence that hospitals that more commonly used early physician follow-up had lower rates of 30-day all-cause readmission. These null findings were similar among high-risk subgroups and for early cardiology follow-up. Although care transitions from hospital to outpatient care after an acute event may still be important, our data do not suggest that generalized use of early physician follow-up will reduce 30-day readmissions among older adults after acute myocardial infarction. Further studies are needed to investigate other approaches to reduce acute myocardial infarction readmissions.
